Epana Biosciences
Biotechnology company building a first-in-class platform to transform the treatment of autoimmune disease using AI-driven insights to develop precision T-cell engagers targeting novel targets.
Investors
1
Categories
autoimmune, ai, t-cell-therapy, therapeutics, biotech, precision-medicine
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| OMX Ventures | San Francisco, California, USA | biotech-focused | seedseries-a | 23 |